These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 28434351)
21. Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Ericzon BG; Wilczek HE; Larsson M; Wijayatunga P; Stangou A; Pena JR; Furtado E; Barroso E; Daniel J; Samuel D; Adam R; Karam V; Poterucha J; Lewis D; Ferraz-Neto BH; Cruz MW; Munar-Ques M; Fabregat J; Ikeda S; Ando Y; Heaton N; Otto G; Suhr O Transplantation; 2015 Sep; 99(9):1847-54. PubMed ID: 26308415 [TBL] [Abstract][Full Text] [Related]
22. Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study. Vollmar J; Schmid JC; Hoppe-Lotichius M; Barreiros AP; Azizi M; Emrich T; Geber C; Schad A; Weyer V; Otto G; Heise M; Mittler J; Birklein F; Lang H; Galle PR; Zimmermann T Transpl Int; 2018 Nov; 31(11):1207-1215. PubMed ID: 30091268 [TBL] [Abstract][Full Text] [Related]
23. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis. Wixner J; Sundström T; Karling P; Anan I; Suhr OB BMC Gastroenterol; 2015 Apr; 15():51. PubMed ID: 25908211 [TBL] [Abstract][Full Text] [Related]
24. Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Snanoudj R; Durrbach A; Gauthier E; Adams D; Samuel D; Ferlicot S; Bedossa P; Prigent A; Bismuth H; Charpentier B Nephrol Dial Transplant; 2004 Jul; 19(7):1779-85. PubMed ID: 15150345 [TBL] [Abstract][Full Text] [Related]
25. Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation. Matsushima M; Yabe I; Tsuda M; Sakakibara M; Shimamura T; Sasaki H Intern Med; 2017 Dec; 56(23):3231-3235. PubMed ID: 28943540 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study. Mizukami M; Ueda M; Tasaki M; Misumi Y; Masuda T; Matsumoto S; Yamashita T; Ando Y Amyloid; 2017 Mar; 24(sup1):122. PubMed ID: 28434327 [No Abstract] [Full Text] [Related]
27. Gene therapy: lessons learned from liver transplantation for transthyretin-amyloidosis. Suhr OB; Holmgren G; Lundgren E Liver Transpl; 2004 Dec; 10(12):1551-3. PubMed ID: 15558840 [No Abstract] [Full Text] [Related]
28. Liver transplantation in transthyretin amyloidoses. When the neurological benefit outweighs the risk. Mascalchi M; Salvi F Neurol Sci; 2006 Nov; 27(5):297-8. PubMed ID: 17122935 [No Abstract] [Full Text] [Related]
36. Perioperative management for liver transplant in a patient with familial amyloid polyneuropathy with heart involvement. López-Herrera Rodríguez D; Guerrero Domínguez R; Mellado Miras P; Gómez Sosa L Rev Esp Anestesiol Reanim; 2015 Jan; 62(1):46-8. PubMed ID: 24742789 [TBL] [Abstract][Full Text] [Related]
37. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients. Oguchi K; Takei Y; Ikeda S Amyloid; 2006 Jun; 13(2):99-107. PubMed ID: 16911964 [TBL] [Abstract][Full Text] [Related]
38. Anticipation of presbyopia in Portuguese familial amyloidosis ATTR V30M. Beirão M; Matos E; Beirâo I; Costa PP; Torres P Amyloid; 2011 Sep; 18(3):92-7. PubMed ID: 21591979 [TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation. Okumura K; Yamashita T; Masuda T; Misumi Y; Ueda A; Ueda M; Obayashi K; Jono H; Yamashita S; Inomata Y; Ando Y Amyloid; 2016; 23(1):39-45. PubMed ID: 26763274 [TBL] [Abstract][Full Text] [Related]